Tarsus Pharmaceuticals Statistics
NASDAQ: TARSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
73.01-4.66 (-6.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tarsus Pharmaceuticals by the numbers
Tarsus Pharmaceuticals has a market capitalization of $3.60 billion based on 49.31M shares outstanding. With trailing EPS of $-15.86, Tarsus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.5% below its 50-day average and 6.9% above its 200-day average.
Average daily trading volume is 871.07K shares, or about $63.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TARS valuation vs. peer median
| Metric | TARS | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.60B | $3.07B | +17% |
| Avg. volume | 871.07K | 2.12M | -59% |
Peer median across 8 companies: RLAY, CRSP, IOVA, DNLI, VCEL, ADMA, ADPT, BEAM.
Valuation
- Market cap
- $3.60B
- Forward P/E
- 339.58
- Price / sales (latest FY)
- 7.98
- EPS (TTM)
- $-15.86
- Shares outstanding
- 49.31M
Price and trading
- Previous close
- 77.67
- Open
- 77.09
- Day range
- 72.74 – 78.11
- 52-week range
- 53.89 – 91.53
- 52-week change
- -8.35%
- Beta
- —
- Volume
- 706.77K
- Average volume
- 871.07K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 3.60B
- Forward Pe
- 339.58
- Eps
- -15.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 91.53
- Week52 Low
- 53.89
- Avg Volume
- 871.07K
- Shares Outstanding
- 49.31M
- Ma50
- 74.09
- Ma200
- 68.27
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -20.23%
- Pct From52w Low
- 35.48%